Entera Bio Ltd.
ENTX
$2.06
-$0.16-7.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.47% | 5.51% | 8.52% | 16.75% | 50.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.30% | 20.07% | 26.33% | 23.23% | 28.37% |
| Operating Income | -7.78% | -23.23% | -24.30% | -19.05% | -26.61% |
| Income Before Tax | -5.93% | -23.82% | -27.27% | -17.49% | -28.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.93% | -23.82% | -27.27% | -18.20% | -26.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.93% | -23.82% | -27.27% | -18.20% | -26.99% |
| EBIT | -7.78% | -23.23% | -24.30% | -19.05% | -26.61% |
| EBITDA | -7.91% | -23.54% | -24.69% | -19.28% | -26.90% |
| EPS Basic | 15.32% | 1.90% | -7.83% | 10.53% | 2.78% |
| Normalized Basic EPS | 15.34% | 1.94% | -7.87% | 10.93% | 1.57% |
| EPS Diluted | 15.32% | 1.90% | -7.83% | 10.53% | 2.78% |
| Normalized Diluted EPS | 15.34% | 1.94% | -7.87% | 10.93% | 1.57% |
| Average Basic Shares Outstanding | 25.09% | 26.28% | 18.08% | 32.15% | 30.65% |
| Average Diluted Shares Outstanding | 25.09% | 26.28% | 18.08% | 32.15% | 30.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |